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Abstract 
 
The Study Within A Trial (SWAT) programme exists to ‘embed research within 
research, so as to resolve uncertainties about the different ways of designing, 
conducting, analysing and interpreting evaluations of health and social care’ (1). 
Published in this journal in 2013, a template for the first SWAT protocol outlined an 
investigation into the effects of site visits by the Principal Investigator on recruitment 
in multi-centre randomized controlled trials (1). We have now designed a SWAT 
protocol to extend this question and ask ‘does it matter who conducts the site visit?’ 
Our aim is to provide a protocol which trials can implement to address this research 
question. 
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Introduction 
 
Randomised controlled trials (RCTs) are commonly viewed as the ‘gold standard’ 
design for producing high quality evidence in medicine. However, recruiting 
participants to a trial or study can be a difficult process, and a high percentage fail to 
reach the recruitment target necessary for an adequately powered study (2, 3). This 
can result in uninterpretable/ambiguous findings or early closure of the trial (4) and 
create ethical issues. 
 
One cause of under-recruitment may be lack of recruitment activity by clinicians. For 
example, in a large primary care cohort study of cough and respiratory tract infection 
in children (5) the authors reported that of the 247 practices that signed up to the trial, 
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as many as 1/5 did not start recruitment (reasons for non-recruitment were not 
stated). At best this represents a huge waste of resources and at worst, the failure of 
the study. 
 
To address this common problem, Fletcher et al. conducted a systematic review of 
interventions aimed at improving recruitment activity of clinicians in RCTs (6). Effective 
interventions included the use of qualitative research to identify and overcome 
barriers to recruitment, reduction of the clinical workload associated with 
participation in RCTs and the provision of extra training and protected research time. 
However, the authors concluded that the interventions were tested mainly in low 
quality studies and no firm recommendations from the review could be made. They 
highlighted that many of the studies focused solely on under recruiters and suggested 
future studies examine factors associated with successful recruitment. 
 
Subsequently, in their large primary care study, Redmond et al. focused on factors 
associated with high recruiting centres. Of the nine factors they examined, only three 
were significantly associated with high recruitment: longer duration of recruitment, 
higher number of recruiting clinicians per site, and shorter time taken to recruit first 
participant (5). The authors concluded that to maximise recruitment, trialists should 
ensure practices have a long duration of recruitment, at least four recruiting clinicians 
per practice and should monitor recruitment closely, addressing practices that fail to 
recruit within the first two weeks. Currently, it is common practice within our trial unit 
to monitor and visit sites which have been initiated but not started recruitment, or 
those with low recruitment rates, to problem solve any issues and encourage them to 
start/improve. However, we have yet to measure in a systematic way whether this site 
visit has any significant impact. 
 
The results of a Study Within A Trial (SWAT-1) designed to assess the effectiveness of 
a ‘site visit’ intervention on recruitment rates in a multi-centre randomised trial were 
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recently published (7). The site visit and scheduled meeting had the sole purpose of 
discussing trial recruitment. The authors compared recruitment rates pre- and post-
intervention in Site A who received the visit, against Sites B and C which did not. They 
found a significant increase in recruitment in the site that received the visit versus the 
controls, indicating that this maybe a useful method for addressing under-recruitment 
in trials. 
 
This SWAT protocol  extends  the work of SWAT-1 by providing a protocol to  examine 
whether site visits not only have the potential to improve recruitment, but also to 
initiate recruitment in those sites which have not yet started. However, the main aim 
of the SWAT protocol is to investigate: does it matter who conducts the visit? 
 
The visits in SWAT-1 were made by the Principal Investigator (PI). PIs are can either be 
clinical staff who also conduct research eg. GPs, consultants or they might be non-
clinical researchers, that is researchers who do not have a clinical background. In our 
unit, it would be common for the Trial Manager to make the site visits. Trial Managers 
are commonly non-clinical researchers. A systematic review summarising the evidence 
related to the impact of feedback on physicians’ clinical performance found that the 
source of the feedback was important (8). Feedback had more effect on performance 
if it came from a professional or administrative group, than if it came from a 
researcher. Could this also apply to trial performance and activity, and if so, does it 
matter who conducts the site visit?   
 
Aim 
 
Our aim is to outline a protocol for a SWAT to investigate whether site visits intended 
to initiate recruitment in sites that are failing to recruit are more effective when 
conducted by a clinical peer rather than a non-clinical member of the research team. 
By clinical peer, we mean a person from the same professional group as the person in 
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charge of recruitment at the site eg. GP, nurse, consultant, who is affiliated with the 
central trial team running the study, but not a key research member of their team. We 
envisage that this SWAT protocol can be incorporated into trials in which some sites 
fail to commence recruitment, and the results can be pooled in a meta-analysis. 
 
Theory 
 
In Social Psychology, ‘conformity’ is the term used to describe the process in which a 
person alters their behaviour based on the influence of other people. One common 
reason for conforming is that we wished to be liked and accepted by others. This may 
lead us to change our behaviour to fit with theirs, or to match their positive 
expectations of us. We do what others do or ask of us so that we do not attract 
attention and to avoid getting into trouble. This is known as Normative Social Influence 
and is incorporated into Social Identity Theory [SIT: (9, 10)]. SIT describes how people 
identify themselves and respond to other. The theory suggests that: 
1. People allocate themselves to groups they belong to (in groups) and groups 
they don’t belong (out groups). For example, groups based on class, occupation, 
political orientation and hobbies. 
2. People gain their identity and self-esteem from these groups. 
3. People are more likely to conform to in groups (same group) than out groups 
(different group). 
The third point indicates that people are more likely to conform, that is, alter their 
behaviour, when asked to do so by people they identify with, from the same group as 
themselves. The implication for this SWAT is that recruiting clinicians are more likely 
to conform to encouragement to commence recruitment from fellow clinicians (peers) 
with whom they identify (in group) than they are to requests from non-clinical 
researchers (out group). Therefore a visit from a clinical peer may be more effective 
at changing the clinician’s recruitment activity than a visit from a non-clinical member 
of the research team. 
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Design 
 
Intervention and Comparator 
 
The intervention will be a face-to-face site visit and meeting by a clinical peer to sites 
that fail to recruit a participant within a specified time frame following site initiation. 
The choice of clinical peer will be study specific and reflective of the person to be 
visited. As an example, if GPs are the main recruiters in a study, a GP trained in the 
study procedures and working with the study team would be asked to visit the non-
recruiting site. The control will be a face-to-face site visit and meeting by a non-clinical 
research member of the trial team, for example, a Trial Manager or possibly the 
Principal Investigator (as long as they are not also a clinical peer). Details of what the 
visit would entail will change depending on the type of study, nature of practice and 
recruitment process, but examples include reviewing study specific SOPs with the 
recruitment team, ensuring they have up-to-date contact details in the event of 
queries, checking that recruitment materials are readily available and that 
promotional posters and leaflets are being displayed. 
 
Allocation to Intervention and Comparator 
 
Recruiting sites who fail to recruit a participant within a pre-agreed time period after 
initiation would be randomly allocated to intervention or control via simple 
randomization. The main trial statistician should perform the allocation using any valid 
simple randomisation method. The pre-agreed time frame will vary depending on the 
nature of the condition under investigation, with some conditions being very common 
and others rarer. As an example, in GP practices recruiting to a respiratory tract 
infections study, Redmond et al (2015) have recommended addressing practices that 
fail to recruit within the first two weeks following initiation. 
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Primary Outcomes 
 
The primary outcome measure will be the number of days to first recruit following the 
site visit.  
 
Secondary Outcomes 
 
The secondary outcome measure will be the total number of participants recruited at 
the end of the study. 
 
Analysis 
 
The primary outcome would be compared between groups (those receiving a visit 
from a clinical peer or a non-clinical member of the research team) using survival 
analysis. The unit of analysis is site. Hazard ratios with associated 95% confidence 
intervals would summarise the results. Descriptive statistics will compare the total 
number of recruits between trial arms.  
 
Possible Problems 
 
Studies would need to be large enough to have sufficient sites to randomize non-
recruiting sites to two arms. This may be more feasible in large primary care studies 
than in secondary care studies with fewer sites. However, whilst small studies may not 
be able to definitively demonstrate effectiveness, they could contribute to a meta-
analysis, which demonstrates the importance of using a standard protocol such as this 
one. Another issue to consider is that the research teams would also need an available 
peer clinician, willing and able to make site visits. 
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Link to the SWAT Repository 
 
http://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/SWATSWA
RInformation/Repositories/SWATStore/ 
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